Qureight appointed imaging CRO for Phase 3 SURPASS-IPF trial as partnership with Celea Therapeutics expands

by rss feed | Oct 21, 2026 | News Feeds

Qureight, an end-to-end imaging CRO providing enterprise-grade imaging and precision endpoints for clinical trials for lung and heart disease, today announced it has been selected by Celea Therapeutics as the imaging CRO to support Celea’s Phase 3 SURPASS-IPF clinical...

Why did people report feeling better during COVID-19? A French study offers clues

by rss feed | Oct 21, 2026 | News Feeds

Assessing well-being in France (2014-2023), the study finds COVID-19 influenced scores, with health symptoms significantly affecting emotional health. Read Original...

Young adults increasingly use high-nicotine e-cigarettes, study finds

by rss feed | Oct 21, 2026 | News Feeds

Researchers from University of California San Diego Herbert Wertheim School of Public Health and Human Longevity Science have found that high-nicotine e-cigarette use rose sharply among young adults between 2017 and 2022 and was associated with increased nicotine...

Duke initiative aims to bring dementia AI tools into clinical practice

by rss feed | Oct 21, 2026 | News Feeds

Artificial intelligence (AI) could transform care for older adults and people living with dementia, but few tools have successfully moved from research into routine clinical practice. Read Original...

Diverse social activities may help slow age-related cognitive decline

by rss feed | Oct 21, 2026 | News Feeds

Diverse and sustained social activities may boost cognitive performance and slow the decline in brain health associated with aging, suggest the findings of a large international study, published online in the Journal of Epidemiology & Community Health. Read Original...